Systems Biology Will Direct Vascular-Targeted Therapy for Obesity

Area of Science:

• * Integrative biology
• * Systems biology
• * Vascular biology

Background:

• * Adipose tissue expansion and metabolism during weight gain depend on coordinated angiogenesis and lymphangiogenesis, regulated by vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).
• * Dysregulated angiogenesis and lymphangiogenesis in obesity are linked to chronic inflammation, hypoxia, immune cell accumulation, and fibrosis, contributing to metabolic disorders.
• * Targeting VEGF:VEGFR signaling offers a potential therapeutic strategy for obesity by normalizing vascular growth and mitigating adverse metabolic consequences.

Purpose of the Study:

• * To systematically investigate the interdependence of vascular and metabolic systems in obesity.
• * To explore the role of VEGF:VEGFR signaling in angiogenesis, lymphangiogenesis, adipogenesis, and macrophage specification.
• * To identify computational and quantitative approaches for developing personalized vascular-targeted therapies for obesity.

Main Methods:

• * Review of existing literature on VEGF:VEGFR signaling in adipose tissue.
• * Discussion of systems biology principles and computational modeling techniques.
• * Detailing quantitative methods for acquiring tissue-specific parameters.

Main Results:

• * VEGF:VEGFR signaling is a critical regulator of adipose tissue expansion and metabolism.
• * Systems biology can identify key signaling mechanisms for therapeutic targeting.
• * Computational models and quantitative data are essential for predicting treatment outcomes.

Conclusions:

• * Normalizing VEGF:VEGFR signaling is a promising strategy for obesity treatment.
• * Systems biology approaches can guide the development of effective vascular-targeted therapies.
• * Personalized treatment strategies require accurate computational models and quantitative data.